Augusto Miravalle, M.D., FAAN


amiravalle@ufl.edu

Dr. Miravalle is an Associate Professor, Associate Chair of Education and Chief of the Multiple Sclerosis Division at the University of Florida, College of Medicine.  He sub-specializes in Multiple Sclerosis and related neuro-immunological disorders of the brain and spinal cord.  He has particular interest in gray matter pathology, particularly neocortical volume changes, cortical lesions, and their impact on cognitive and physical disability. Dr. Miravalle has been involved in both clinical and science based research.  He is a member of many professional societies and advisory boards. He has published numerous scientific articles and served as a consultant to various scientific organizations.

As an educator, Dr. Miravalle has been actively involved in direct teaching, development of curricular activities as well as administrative leadership positions.  Before moving to the University of Florida, he served as Residency Program Director and Vice Chair of Education, Chair Clinical Competency Committee for the Residency Program, Chair for the Adult Residency Education Committee, and Chair for Grand Rounds Committee for the Department of Neurology at the University of Colorado.  He developed and implemented several innovative education programs including leadership training for neurology residents, mission based budgeting and educational RVU (eRVU) system and competency-based assessment programs for GME.  As a result of this work, he received the 2015 American Academy of Neurology Education Research Award, and the 2016 American Board of Psychiatry and Neurology Faculty Innovation in Education Award.

Dr. Miravalle received his medical degree at the University of La Plata, Buenos Aires, Argentina.  He completed his Neurology Residency Training at Loyola University where he served as chief resident of education.  He subsequently completed a clinical neuroimmunology fellowship at Harvard University.  Dr. Miravalle was the recipient of the 2012 America Neurological Association Medical Education Fellowship Award.

Clinical Interests

Patient-centered Comprehensive Care for MS Patients
Symptomatic Management in Multiple Sclerosis
Fatigue Management
Wellness in MS

Research Interests

Use of Highly effective Disease Modifying Therapies in Multiple Sclerosis
Comparative effectiveness of various DMTs in MS
MRI correlates with clinical disability in MS

Teaching Interests

Competency-based assessment tools for GME
Entrustable Professional Activities
Mission-Based Budgeting Systems for Medical Education
Educational RVU systems for Graduate Medical Education

Professional Society Affiliations

Fellow Member, American Academy of Neurology
EPA and Competency-Based Assessment Work-group, American Association of Medial Colleges
Member.  A.B. Baker Section Medical Education,  American Academy of Neurology
Member, ELF Graduate Committee,, American Academy of Neurology
Annual Fall Conference Education Committee, American Academy of Neurology

Medical Education

Universidad Nacional de La Plata, La Plata, Argentina, 2001

Internship

Resurrection-Westlake Hospital, Melrose Park, IL, 2005

Residency

Loyola University Medical Center/Hines VA Hospital, Chicago, IL, 2008

Fellowships

Multiple Sclerosis Clinical Fellowship, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 2009
Neuroimaging Research Fellowship,Beth Israel Deaconess Medical Center, Harvard University, Boston, MA 2009
Neurology Teaching Fellowship, University of Rochester, Rochester, NY 2012

Awards and Recognitions

Fellow to the American Academy of Neurology, 2016
Best Doctors in America®” database, 2015-2016
Faculty Innovation in Education Award – American Board of Psychiatry and Neurology, 2015
Administration Program (LEAP)  – University of Colorado, School of Medicine, 2015
Clinical Leadership Development Program (CLD) – University of Colorado, School of Medicine, 2015

Publications

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, Weinstock-Gutman B, Yadav V, Zabeti A. Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.  Contemp Clin Trials. 2016 Sep;50:166-77.

Korb PJ, Miravalle A. Coding in Multiple Sclerosis and Other Demyelinating Diseases.  Continuum (Minneap Minn). 2016 Aug;22(3):951-9.

Harlow DE, Honce JM, Miravalle AA. Remyelination Therapy in Multiple Sclerosis. Front Neurol. 2015 Dec 10;6:257.

Liewluck T, Miravalle A. Immune-Mediated Neurological Disorders. Curr Neurol Neurosci Rep. 2015 Sep;15(9):61.

Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T, Corboy J, Miravalle A, Schreiner T, Porter V, Nair K. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014 Mar;3(2):227-36

To see a complete PubMed list click here.